Research on the Application of Fibroblast-Derived Tissue Engineering Cell Sheets in the Repair of Stress Urinary Incontinence

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2600116164

Enrollment

Unknown

Registered

2026-01-06

Start date

2026-02-01

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress urinary incontinence

Interventions

Experimental Group:Skin tissue of approximately 5mm*5mm in size was obtained from each person (preferably from the surgical site of the perineum, which does not affect the patients appearance), and ce

Eligibility

Sex/Gender

Female

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged 30 to 60; 2. SUI that meets the diagnostic criteria of ICS or AUA; 3. Meet the surgical treatment criteria and have the willingness; 4. Those who are tolerant to surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with urinary system tumors; 2. Accompanied by urinary system diseases such as infection, stones, etc. 3. Pregnant or lactating women; 4. Suffering from severe liver, kidney or cardiovascular diseases; 5. Those who are intolerant to surgery; 6. Those who have no intention of undergoing surgery.

Design outcomes

Primary

Measure	Time frame
The success rate of fibroblast separation;	—

Countries

China

Contacts

Public ContactWei Jiao

Shanghai Fifth People's Hospital, Fudan University

jiaowei1993@qq.com+86 175 2101 2383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026